| |
| |
|
| Insider
Information: |
Reumuth Mary |
| Relationship: |
|
| City: |
Waltham |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
66,136 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$468,243 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
66,136 |
|
|
| Total
Value |
$468,243 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kala Pharmaceuticals, Inc. |
KALA |
|
2024-01-04 |
66,136 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-01-04 |
4 |
AS |
$6.74 |
$8,270 |
D/D |
(1,227) |
66,136 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2024-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
4,600 |
67,363 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
36,144 |
62,763 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2023-05-31 |
4 |
A |
$0.00 |
$0 |
D/D |
14,736 |
26,619 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-06-27 |
4 |
AS |
$0.37 |
$967 |
D/D |
(2,613) |
130,595 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2022-01-04 |
4 |
AS |
$1.30 |
$3,705 |
D/D |
(2,850) |
133,208 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2021-10-26 |
4 |
AS |
$1.80 |
$17,008 |
D/D |
(9,449) |
136,058 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
CHIEF FINANCIAL OFFICER |
• – – |
2021-06-28 |
4 |
AS |
$5.77 |
$14,148 |
D/D |
(2,452) |
145,507 |
0 |
% |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Chief Financial Officer |
• – – |
2021-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
22,666 |
147,959 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Chief Financial Officer |
• – – |
2020-10-26 |
4 |
A |
$0.00 |
$0 |
D/D |
61,000 |
125,293 |
0 |
- |
|
| KALA |
Kala Pharmaceuticals, Inc... |
Chief Financial Officer |
• – – |
2020-06-09 |
4 |
OE |
$2.30 |
$114,771 |
D/D |
43,477 |
48,293 |
0 |
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
